glp-1 receptor agonists cardiovascular benefits and outcome trials: An update In patients with #obesity, incretin-based
Description
doi: 10.1111/anae.14180
His diverse interests span from disc golfing and woodworking to playing the violin and authoring illustrated childrens poetry books, reflecting a unique blend of medical professionalism and creative expression
Glucagon-like peptide-1 receptor agonists: A narrative review of clinical pharmacology and implications for peri-operative practice
24 h 6.4 2.9 cmCSF ( P = 0.030)
However, in diabetic cardiomyopathy, there is a disruption in the quality control of mitochondria, which results in an inadequate fusion process, increased fission, and fragmentation [69]
doi: 10.2337/db18-1123 55 MentisNVardarliIKtheLDHolstJJDeaconCFTheodorakisMet al
